insights_auto
Why is CYAD up 6.07%?
Dive Deeperchevron_right
CYAD:EBR
Celyad Oncology SA
€0.23
arrow_upward
+6.07%(+0.013) 1D
Oct 16, 5:35:08 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYAD...
Open
€0.21
High
€0.23
Low
€0.20
Mkt. cap
10.64M
Avg. vol.
11.20K
Volume
11.85K
P/E ratio
3.02
52-wk high
€0.65
52-wk low
€0.16
EPS
€0.08
Shares outstanding
47.26M
No. of employees
5
Open
€0.21
High
€0.23
Low
€0.20
Mkt. cap
10.64M
Avg. vol.
11.20K
Volume
11.85K
P/E ratio
3.02
52-wk high
€0.65
52-wk low
€0.16
EPS
€0.08
Shares outstanding
47.26M
No. of employees
5
News stories
From web sources and news partners
marketscreener.com
·
44 minutes ago
Nasdaq Falls to End Four-Week Winning Streak Amid Tech Sell-Off
Finimize
·
49 minutes ago
S&P 500’S Tech Slump Put AI Debt In Focus
The Motley Fool
·
51 minutes ago
Inflation Rose to 3.7% in September. Is It Time to Sell the S&P 500?
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersMont-Saint-Guibert, Walloon Brabant, Belgium
SectorBiotechnology
Websitecelyad.com